Wolfgang Wienand, CEO of Lonza, Outlines ‘One Lonza’ Strategy and 2025 Growth Targets

Lonza has provided an overview of its new “One Lonza” strategy and new organizational structure As Lonza focuses on its core CDMO1 busines...

December 12, 2024 | Thursday | News
Hovione Expands Global Footprint with Major Investments in U.S. and Europe

    Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, just completed significant expansions in...

November 27, 2024 | Wednesday | News
Abzena Expands Analytical Capabilities with GMP Cell-Based Potency Assays at Cambridge and San Diego Facilities

" Abzena, a leading CDMO/CRO, now offers GMP cell-based potency assays at its UK and US sites, enhancing its support for complex biologics and ADC programs...

November 20, 2024 | Wednesday | News
Ardena Secures Full GMP Approval for Expanded Nanomedicine Facility in Oss, Netherlands

" Ardena, a leading CDMO, has received full GMP approval for its advanced nanomedicine facility in Oss. This €20 million investment, featuring state...

November 20, 2024 | Wednesday | News
Ardena Expands Bioanalytical Services with New Lab in Oss, Netherlands, Enhancing Capabilities to Meet Growing Client Demand

  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlan...

October 31, 2024 | Thursday | News
Catalent CEO John Chiminski Issues Open Letter Addressing Novo Holdings’ Acquisition and Reaffirms Commitment to Customers

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, issued the following open lette...

October 22, 2024 | Tuesday | News
Ardena Expands Global CDMO Footprint with Acquisition of Catalent’s Somerset Facility

  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlan...

October 15, 2024 | Tuesday | News
NovaCina Expands Perth Facility with Advanced SA25 GMP Filling Line to Enhance Global CDMO Services

NovaCina, a global contract development and manufacturing organization (CDMO), has today announced the expansion of its facility in Perth, Australia with...

October 08, 2024 | Tuesday | News
Enzene Launches Advanced EnzeneX™ 2.0 Platform at CPHI Milan

Enzene, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced it is to launch its new EnzeneX&trad...

October 07, 2024 | Monday | News
Recipharm and Exela Pharma Forge Strategic Alliance to Boost U.S. Sterile Manufacturing with 100+ Million Units Capacity

Sterile manufacturing capability in the US with over 100 million readily-available units (including vials and Pre-Filled Syringes – PFS) Extensi...

October 04, 2024 | Friday | News
Abzena's AbZelectPRO™ Platform Reduces Cell Line Development Timelines by 30%, Boosts Protein Production for Biopharma

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line development platform, ...

September 27, 2024 | Friday | News
Emmes Secures Major NIH Contract to Lead Clinical Coordinating Center for National Institute on Drug Abuse Trials

Emmes, part of Emmes Group, announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials &nbs...

September 26, 2024 | Thursday | News
Shuttle Pharmaceuticals Expands Phase 2 Glioblastoma Trial with Two Additional Sites

Shuttle Pharmaceuticals Holdings, a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients tr...

September 17, 2024 | Tuesday | News
Hongene Biotech and ReciBioPharm Forge Strategic Alliance to Enhance Gene Editing Drug Manufacturing

Hongene Biotech Corporation, a global leader in nucleic acid manufacturing, and ReciBioPharm, a leading advanced therapeutics CDMO services provider, hav...

September 09, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close